Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.8%

2 terminated out of 53 trials

Success Rate

92.9%

+6.4% vs benchmark

Late-Stage Pipeline

15%

8 trials in Phase 3/4

Results Transparency

31%

8 of 26 completed with results

Key Signals

8 with results93% success

Data Visualizations

Phase Distribution

38Total
Not Applicable (15)
Early P 1 (2)
P 1 (3)
P 2 (10)
P 3 (5)
P 4 (3)

Trial Status

Completed26
Unknown6
Recruiting6
Withdrawn5
Not Yet Recruiting5
Active Not Recruiting3

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 26 completed trials

Clinical Trials (53)

Showing 20 of 20 trials
NCT07149428Not Yet Recruiting

Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)

NCT06600438Not ApplicableNot Yet Recruiting

Slow-SPEED UK: A Double-Blind Randomised Feasibility Trial

NCT06733636Not ApplicableRecruiting

Scents of Progress: Leveraging a Novel Device for Olfactory Training in Older Adults

NCT07498062Not ApplicableCompletedPrimary

Multimodal Chewing Gum Flavour Training to Aid Flavour Perception Recovery - a Pilot Study.

NCT05040659Active Not RecruitingPrimary

Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2

NCT05912881Not ApplicableCompletedPrimary

Chemosensory Dysfunction and Recovery in Endoscopic Endonasal Skull Base Surgery

NCT05445921Phase 1CompletedPrimary

Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction

NCT07383415Not ApplicableNot Yet RecruitingPrimary

Intranasal Platelet-Rich Plasma With or Without Topical Insulin for Post-Inflammatory Anosmia

NCT04361474Phase 3Completed

Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity

NCT07151703Phase 3Not Yet Recruiting

Topical Versus Injection PRP for Olfactory Dysfunction

NCT04466982Completed

Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection

NCT05364125Not ApplicableRecruiting

Olfactory Training on Smell Dysfunction Patients in HK

NCT06930248Not ApplicableNot Yet RecruitingPrimary

Efficacy of Platelet-rich Plasma in Management of Anosmia

NCT06498687Phase 1Withdrawn

Theophylline Nasal Spray for PD-Related Hyposmia and Anosmia

NCT05184192Phase 2Completed

Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction

NCT06204432Phase 2Active Not Recruiting

Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction

NCT06766279Not ApplicableRecruitingPrimary

Investigating the Efficacy of OMT to Recover Olfactory Perception After COVID-19

NCT05384561Not ApplicableRecruiting

Olfactory Training As a Treatment for Olfactory Dysfunction Post COVID-19

NCT05562050Active Not RecruitingPrimary

Characteristics of the Anosmic Olfactory Mucosa

NCT04964414Phase 1Terminated

Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19

Scroll to load more

Research Network

Activity Timeline